Literature DB >> 23886200

Expression and significance of TSGF, CEA and AFP in patients before and after radical surgery for colon cancer.

Yi Hu1, Jing-Liang Wang, Hai-Tao Tao, Bai-Shou Wu, Jin Sun, Yao Cheng, Wei-Wei Dong, Rui-Xin Li.   

Abstract

OBJECTIVE: To explore the expression and significance of tumor specific growth factor (TSGF), carcinoembryonic antigen (CEA) and alpha fetoprotein (AFP) in cancer tissue and serum of patients with colon cancer.
MATERIALS AND METHODS: Radical surgery for colon cancer was performed on 43 patients with laparoscope under conditions of general anesthesia. The Elisa method was used to detect the levels of serum TSGF, CEA and AFP before and after radical operation, and cancer tissue underwent TSGF, CEA and AFP immunohistochemistry staining after laparoscopic surgery. The decreased conditions of serum TSGF, CEA and AFP in patients with colon cancer at different levels of differentiation and clinical stagings were analyzed, and the relationships of expression rates between histological types, colon cancer morphology, lymph node metastasis and TSGF, CEA as well as AFP in cancer tissue were assessed.
RESULTS: Compared with before radical surgery, the levels of serum TSGF, CEA and AFP decreased notably in patients after operations (p<0.01). The decreased degree of TSGF and CEA was the largest in patients with poorly differentiated cancer tissue (p<0.01), while that of AFP was noted in patients with moderately differentiated cancer tissue (p<0.01). The decreased degree of TSGF and AFP was the largest in patients at phase Dukes A (p<0.01), while that of CEA in patients at phase Dukes C (p<0.01). There were no significant differences among the positive expression rates of TSGF, CEA and AFP with different histological types and colon cancer morphologies (p>0.05). The positive expression rates of TSGF and CEA in patients with lymph node metastasis were significantly higher than those without lymph node metastasis (p<0.01).
CONCLUSIONS: TSGF, CEA and AFP can be used to evaluate the effect of radical operation for colon cancer, and the changed levels of different markers are associated with tumor differentiation, clinical stating and presence or absence of lymph node metastasis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23886200     DOI: 10.7314/apjcp.2013.14.6.3877

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  9 in total

1.  Impact Of Circulating T Helper 1 And 17 Cells in the Blood on Regional Lymph Node Invasion in Colorectal Cancer.

Authors:  Ji Yeon Lee; Eun-Hye Seo; Chung-Sik Oh; Jin-Hee Paik; Dae-Yong Hwang; Seung Hyun Lee; Seong-Hyop Kim
Journal:  J Cancer       Date:  2017-05-10       Impact factor: 4.207

2.  Intestinal differentiated mucinous adenocarcinoma of the endometrium with sporadic MSI high status: a case report.

Authors:  Mafalda Trippel; Sara Imboden; Andrea Papadia; Michael D Mueller; Nando Mertineit; Kirsi Härmä; Alina Nicolae; Erik Vassella; Tilman T Rau
Journal:  Diagn Pathol       Date:  2017-05-12       Impact factor: 2.644

3.  Circulating tumor DNA detectable in early- and late-stage colorectal cancer patients.

Authors:  Ying-Chi Yang; Dong Wang; Lan Jin; Hong-Wei Yao; Jing-Hui Zhang; Jin Wang; Xiao-Mu Zhao; Chun-Ying Shen; Wei Chen; Xue-Liang Wang; Rong Shi; Si-Yi Chen; Zhong-Tao Zhang
Journal:  Biosci Rep       Date:  2018-07-31       Impact factor: 3.840

4.  Prognostic Values Of Preoperative Serum CEA And CA125 Levels And Nomograms For Young Breast Cancer Patients.

Authors:  Xuan Li; Danian Dai; Bo Chen; Sirong He; Jie Zhang; Chunjie Wen; Bin Wang
Journal:  Onco Targets Ther       Date:  2019-10-24       Impact factor: 4.147

5.  The Predicting Role of Serum TSGF and sIL-2R for the Lymph Node Metastasis of Papillary Thyroid Carcinoma.

Authors:  Xiaoqin Xu; Weigang Wang; Ting Sun; Baoguo Tian; Lili Du; Jiexian Jing
Journal:  Dis Markers       Date:  2022-09-02       Impact factor: 3.464

6.  Plasma DNA Integrity as a Prognostic Biomarker for Colorectal Cancer Chemotherapy.

Authors:  Feng Zhu; Jing Ma; Dongdong Ru; Ningning Wu; Yunhua Zhang; Huiyuan Li; Xiaoli Liu; Jianfeng Li; Huiling Zhang; Yue Xu; Jiangman Zhao; Hui Tang; Yusheng Wang; Weihua Fu
Journal:  J Oncol       Date:  2021-05-26       Impact factor: 4.375

7.  Aberrant Non-Coding RNA Expressed in Gastric Cancer and Its Diagnostic Value.

Authors:  Zhilong Yu; ZeYin Rong; Jinxin Sheng; Zai Luo; Jianming Zhang; Tengfei Li; Zhonglin Zhu; Zhongmao Fu; Zhengjun Qiu; Chen Huang
Journal:  Front Oncol       Date:  2021-07-06       Impact factor: 6.244

Review 8.  Biomarkers in Urachal Cancer and Adenocarcinomas in the Bladder: A Comprehensive Review Supplemented by Own Data.

Authors:  Henning Reis; Ulrich Krafft; Christian Niedworok; Orsolya Módos; Thomas Herold; Mark Behrendt; Hikmat Al-Ahmadie; Boris Hadaschik; Peter Nyirady; Tibor Szarvas
Journal:  Dis Markers       Date:  2018-03-12       Impact factor: 3.434

9.  Preventive and therapeutic effect of intraportal oridonin on BALb/c nude mice hemispleen model of colon cancer liver metastasis.

Authors:  Yu-Shen Yang; Dan Wen; Xue-Feng Zhao
Journal:  Transl Cancer Res       Date:  2021-03       Impact factor: 1.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.